title: Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by Toll-like receptors.
abstract: The angiogenic response to injury can be studied by culturing rat or mouse aortic explants in collagen gels. Gene expression studies show that aortic angiogenesis is preceded by an immune reaction with overexpression of Toll-like receptors (TLRs) and TLR-inducible genes. TLR1, 3, and 6 are transiently upregulated at 24 h whereas TLR2, 4, and 8 expression peaks at 24 h but remains elevated during angiogenesis and vascular regression. Expression of TLR5, 7 and 9 steadily increases over time and is highest during vascular regression. Studies with isolated cells show that TLRs are expressed at higher levels in aortic macrophages compared to endothelial or mural cells with the exception of TLR2 and TLR9 which are more abundant in the aortic endothelium. LPS and other TLR ligands dose dependently stimulate angiogenesis and vascular endothelial growth factor production. TLR9 ligands also influence the behavior of nonendothelial cell types by blocking mural cell recruitment and inducing formation of multinucleated giant cells by macrophages. TLR9-induced mural cell depletion is associated with reduced expression of the mural cell recruiting factor PDGFB. The spontaneous angiogenic response of the aortic rings to injury is reduced in cultures from mice deficient in myeloid differentiation primary response 88 (MyD88), a key adapter molecule of TLRs, and following treatment with an inhibitor of the NFκB pathway. These results suggest that the TLR system participates in the angiogenic response of the vessel wall to injury and may play an important role in the regulation of inflammatory angiogenesis in reactive and pathologic processes.
authors.affiliation: Department of Pathology, University of Washington, Seattle, WA, USA.
authors.forename: Alfred C
authors.initials: AC
authors.lastname: Aplin
authors.forename: Giovanni
authors.initials: G
authors.lastname: Ligresti
authors.forename: Eric
authors.initials: E
authors.lastname: Fogel
authors.forename: Penelope
authors.initials: P
authors.lastname: Zorzi
authors.forename: Kelly
authors.initials: K
authors.lastname: Smith
authors.forename: Roberto F
authors.initials: RF
authors.lastname: Nicosia
mesh_terms: D063194:Adventitia / Q000166:cytology / Q000378:metabolism*; D000818:Animals; D001011:Aorta / Q000166:cytology / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D008070:Lipopolysaccharides / Q000633:toxicity; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D020574:Proto-Oncogene Proteins c-sis / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D051193:Toll-Like Receptors / Q000096:biosynthesis* / Q000235:genetics; D017539:Tunica Intima / Q000166:cytology / Q000378:metabolism
chemical_list: D008070:Lipopolysaccharides; C507780:Myd88 protein, mouse; C507781:Myd88 protein, rat; D053594:Myeloid Differentiation Factor 88; D020574:Proto-Oncogene Proteins c-sis; D051193:Toll-Like Receptors